Compliance Blogs

01|21|25

2025 Data Privacy Landscape: Is Pharma Ready for the Scrutiny?

The data privacy landscape in 2025 presents new risks for pharmaceutical companies due to a surge in state-specific privacy laws in the U.S., evolving global regulations and increased scrutiny of artificial intelligence (AI) technologies. Today, compliance is essential for maintaining consumer trust, protecting sensitive health data and avoiding regulatory penalties. Access the POV to learn how your brand can prepare for the changes in the 2025 data privacy landscape.